Timber Pharmaceuticals Inc. (AMEX: TMBR) 7.53% Incline Turns Investors Off From Company Stock

Timber Pharmaceuticals Inc. (AMEX:TMBR) traded at $2.00 at close of the session on Friday, 06/16/23, made an upward move of 7.53% on its previous day’s price.

Looking at the stock we see that its previous close was $1.86 with the day’s price range being $1.87 – $2.02. In terms of its 52-week price range, TMBR has a high of $16.99 and a low of $1.20. The company’s stock has gained about 40.85% over that past 30 days.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it’s about to change everything we know about everything. According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.

Sponsored

Timber Pharmaceuticals Inc. has a market cap of $5.70 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.79, with the EPS growth for the year raised at -$2.95 for 2023 and -$1.62 for next year. These figures represent 67.90% and 45.10% growth in EPS for the two years respectively.

Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $200k, with a low of $200k and a high of $200k. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2023 is expected to hit $800k, or 863.90% up from figures reported last year.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the TMBR stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of Hold.

Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Timber Pharmaceuticals Inc. (TMBR) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is 23.85% off its SMA20 and 29.00% from its 50-day simple moving average. The RSI (14) is pointing at 63.24 while the volatility over the past week is 9.84% and jumps to 10.27% over the past one month. The beta value is 0.08, while the average true range (ATR) is currently pointing at 0.19. The average price target for the stock over the next 12 months is $11.00, with the estimates having a low of $11.00 and a high of $11.00. These price ends are -450.0% and -450.0% off the current price level respectively, although investors could be excited at the prospect of a -450.0% if the TMBR share price touches on the median price of $11.00.

Coming back to Timber Pharmaceuticals Inc. (AMEX:TMBR), we note that the average 3-month trading volume was 458.06K, while that of the preceding 10-day period stands at 1.75 million. Current shares outstanding are 3.04 million.

The insiders hold 0.72% of the company’s shares while institutions hold 4.30%. The data shows that short shares as of May 30, 2023, stood at 23990.0 at a short ratio of 1.03. This represents a 0.79% short interest in shares outstanding on May 30, 2023. Shares short rose in May from the previous month at 23200.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 14.29% up in year-to-date price movement.